FF
RMD icon

Friedenthal Financial’s ResMed RMD Stock Holding History

Friedenthal Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,869
Closed -$1.06M – 301
2025
Q3 		$1.06M Buy
+3,869
New +$1.06M 0.55% 37
2024
Q4 		– Sell
-200
Closed -$48.8K – 318
2024
Q3 		$48.8K Sell
200
-51
-20% -$11.4K 0.03% 168
2024
Q2 		$48K Buy
+251
New +$50.9K 0.03% 164

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Friedenthal Financial's RMD Position: Q4 2025 in Review

Friedenthal Financial sold out of ResMed (RMD) in Q4 2025, closing a stake of 3,869 shares — an estimated $1.06M sold.

Friedenthal Financial first reported a position in RMD in Q2 2024 and held it in 3 quarters. The position peaked at $1.06M in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Friedenthal Financial reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Friedenthal Financial sold 3,869 ResMed shares in Q4 2025, an estimated $1.06M.
  • Friedenthal Financial first reported a position in ResMed in Q2 2024 and held it in 3 quarters.
  • Friedenthal Financial's ResMed position peaked at $1.06M in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Friedenthal Financial's 13F filing for Q4 2025, filed 27 Jan 2026.